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Abstract
Background Recent studies have indicated that unman-
aged pain, both acute and chronic, can affect mental status
and might precipitate delirium, especially in elderly
patients with hip fractures. The aim of this study was to
assess the effectiveness of fascia iliaca compartment block
(FICB) for prevention of perioperative delirium in hip
surgery patients who were at intermediate or high risk for
this complication.
Materials and methods On admission, all included
patients were divided into three groups according to low,
intermediate or high risk for perioperative delirium. Eli-
gible patients (those classiﬁed as at intermediate or high
risk for developing delirium) were sequentially randomly
assigned to study treatment (FICB prophylaxis or placebo)
according to a computer-generated randomization code.
The primary outcome was perioperative delirium. Diag-
nosis of the syndrome was deﬁned using the Diagnostic
and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) and Confusion Assessment Method (CAM)
criteria. Secondary outcome variables were severity of
delirium and delirium duration.
Results Delirium occurred in 33 (15.94%) out of 207
patients randomized to FICB prophylaxis or the placebo
group. Incidence of delirium in the FICB prophylaxis
group was 10.78% (11/102), signiﬁcantly different from
the incidence (23.8%, 25/105) in the placebo group [rela-
tive risk 0.45, 95% conﬁdence interval (CI) 0.23–0.87].
Nine of 17 patients with high risk for delirium and included
in the FICB prophylaxis group developed delirium,
whereas 10 of 16 high-risk patients included in the placebo
group became delirious (relative risk 0.84, CI 0.47–1.52).
Two of 85 patients with intermediate risk for delirium and
included in the FICB prophylaxis group developed delir-
ium, whereas 15 of 89 intermediate-risk patients included
in the placebo group became delirious (relative risk 0.13,
CI 0.03–0.53). Severity of delirium according to the
highest value of the DRSR-98 during an episode with
delirium in patients in the FICB prophylaxis group was on
average 14.34, versus 18.61 in the placebo group (mean
difference 4.27, 95% CI 1.8–5.64, P\0.001). Mean
duration of delirium in the FICB prophylaxis group was
signiﬁcantly shorter than in the placebo group (FICB
5.22 days versus placebo 10.97 days, 95% CI 3.87–7.62,
P\0.001).
Conclusion No signiﬁcant difference was found among
high-risk patients between FICB prophylaxis and placebo
groups in terms of delirium incidence. However, FICB
prophylaxis signiﬁcantly prevented delirium occurrence in
intermediate-risk patients. Thus FICB prophylaxis could be
beneﬁcial, particularly for intermediate-risk patients.
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Introduction
Delirium or acute confusional state is deﬁned as a dis-
turbance of consciousness with inattention accompanied
by a change in cognition or perceptual disturbance that
develops over a short period (hours to days) and ﬂuctuates
over time [1]. Three subtypes of acute confusional state
are recognized: hyperactive, hypoactive, and mixed.
Hyperactive delirium is rare in the pure form and is
associated with a better overall prognosis [2]. It is char-
acterized by agitation, restlessness, attempting to remove
catheters, and emotional lability [3]. Hypoactive delirium,
which is very common and often more deleterious for the
patient in the long term, remains unrecognized in 66–84%
of hospitalized patients, because hypoactivity on the part
of a patient does not seem like a problem and may be
missed [4–6]. This subtype is characterized by with-
drawal, ﬂat affect, apathy, lethargy, and decreased
responsiveness [7].
Delirium is a common complication seen after hip
fracture, affecting approximately 10–16% of patients [8].
It is associated with increased mortality at 1 year,
delayed rehabilitation efforts, prolonged length of hos-
pital stay, poorer functional outcomes, and increased risk
of nursing home placement [9]. Although there are many
hypothesized pathophysiologic mechanisms involved in
the development of delirium, most are thought related to
imbalances in neurotransmitters that modulate cognition,
behavior, and mood [2, 3]. Predisposing factors to
delirium include older age, diagnosis of dementia,
depression, alcoholism, vision or hearing loss, history of
mental status changes, mobility impairment, and dehy-
dration [4, 6]. Hospital-related or iatrogenic factors
include physical restraints, malnutrition, more than three
medications added, use of a bladder catheter, hypoxia,
metabolic disturbances, electrolyte imbalances, with-
drawal syndromes, acute infection (systemic and intra-
cranial), seizures, hyperthermia, head trauma, vascular
disorders, immobilization, sleep deﬁciency, psychiatric
medications, and intracranial space-occupying lesions
[4, 7].
Besides, hip fracture patients are at increased risk of
delirium due to severe pain experienced upon arrival at the
emergency department [10]. Findings from laboratory
studies indicate that unmanaged pain, both acute and
chronic, can affect mental status and might precipitate
delirium, especially in elderly patients with hip fractures,
who usually report a 50–70% incidence of severe pain in
the ﬁrst 24 h post injury [11, 12].
The aim of our study was to assess the effectiveness of
fascia iliaca compartment block (FICB) for prevention of
perioperative delirium in hip surgery patients who were at
intermediate or high risk for this complication. The main
hypothesis tested in this study was that FICB prophylaxis
reduces delirium incidence in hip fracture patients.
Materials and methods
This was a prospective, randomized, placebo-controlled,
clinical trial. A research team of orthopedic surgeons,
neurologists, and nurses in a single 980-bed hospital,
identiﬁed potentially eligible patients by systematically
screening new admissions to one orthopedic ward, from
July 2004 until March 2008. The study was approved by
the local Ethics Committee and all patients signed
informed consent. The study was performed in accordance
with the ethical standards of the 1964 Declaration of Hel-
sinki as revised in 2000.
Men and women aged 70 years and older admitted for
hip fracture were considered for inclusion in the FICB
prophylaxis study. Patients were excluded if they had
delirium at admission, metastatic hip cancer, history of
bupivacaine allergy, use of cholinesterase inhibitors, severe
coagulopathy, Parkinsonism, epilepsy, levodopa treatment,
delay of surgery of more than 72 h after admission, and
inability to participate in interviews (profound dementia,
respiratory isolation, intubation, aphasia, coma or terminal
illness).
Initially, on admission, all included patients were divi-
ded into three groups, according to whether they were low,
intermediate or high risk for perioperative delirium. Risk
classiﬁcation was based on presence of four predictive risk
factors (severity of illness, measured using acute physiol-
ogy age and chronic health examination, cognitive
impairment, measured using the mini-mental state exami-
nation score, index of dehydration, measured using the
ratio of blood urea nitrogen to creatinine, and visual
impairment, measured using the standardized Snellen test)
as described by Inouye et al. [13, 14]. Intermediate risk for
postoperative delirium was deﬁned as presence of one or
two risk factors; high risk was deﬁned as presence of three
or more risk factors.
Eligible patients (those classiﬁed as being at intermediate
or high risk for developing delirium) were sequentially
randomly assigned to study treatment (FICB prophylaxis or
placebo), according to a computer-generated randomization
code. All participants were blinded to the treatment group.
FICB was administered with a 0.25 mg dose of 0.3 mL/kg
bupivacaine on admission and repeated daily every 24 h
until delirium occurrence or hip surgery was performed.
Twenty-four hours after hip surgery the same dose of FICB
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123was re-administered and repeated daily every 24 h until
delirium occurrence or discharge. A standardized FICB
technique was used for the patients, as reported by Dalens
et al. [15] without the need for a nerve stimulator, per-
formed by orthopaedic surgeons. According to their tech-
nique, the puncture site is marked 1 cm caudal to the point
dividing the lateral third and medial two-thirds of a line
extended from the pubic tubercle to the anterior superior
iliac spine. The skin is pierced with a sharp 24-gage needle,
inserted perpendicular to the puncture site. Loss of resis-
tance is noted ﬁrst on passing the fascia lata and second on
passing the fascia iliaca. After the second loss of resistance,
a 0.25 mg dose of 0.3 mL/kg bupivacaine is injected
slowly.
Block efﬁcacy was tested by assessing sensory loss over
the hip fracture area. An early predictor of optimal pain
relief was sensory block of the inner thigh. Although con-
tinuous infusion of bupivacaine could be more convenient
rather repeated blocks, complications such as overdose
could occur. Placebo medication (water for injection) was
identical in appearance to the active drug and was admin-
istered at the same site and in the same way as the FICB was
injected. Intravenous and intramuscular analgesics were
administered as needed in both groups. In these cases the
patients received paracetamol intravenously (ampules
for intravenous infusion of paracetamol 1 g/6.7 ml) and
intramuscularly pethidine (50 mg) occasionally. Low-risk
patients received no prophylactic medication.
Baseline screening and assessments were completed
before hip surgery, within 12 h after admission, and
included:
• Barthel index (range 0–20, lower scores indicating
more functional dependency) [16]
• Chart review to determine APACHE II score (scale of
0–70, with a cutoff score of 16 or higher indicating
increased severity of clinical status) [17]
• Geriatric Depression Scale (15-item version self-rating
scale for depression, range 0–15, higher scores indi-
cating depression) [18]
• Pre-existing cognitive impairment (mini-mental state
examination (MMSE) score B24 on a scale of 0–30)
[19]
• Ratio of blood urea nitrogen to creatinine
• Standardized Snellen test for visual impairment [20]
The primary outcome was perioperative delirium.
Diagnosis of the syndrome was deﬁned using the Diag-
nostic and Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) and Confusion Assessment Method
(CAM) criteria [1, 21].
Secondary outcome variables were severity of delirium,
delirium duration, and pain score. Delirium severity was
measured using the Delirium Rating Scale, revised version-
98 [DRS-R-98, range 0 (no severity) to 45 (high severity)]
[22]. Daily patient assessments using the MMSE, DRS-R-
98, and Digit Span test [assessment of attention, range 0
(no attention) to 42 (good attention)] were used to enable
the DSM-IV and CAM diagnoses and assess delirium
severity [23]. CAM and DRS-R-98 assessments were
continued once delirium was diagnosed. This prospective
study involved the use of a visual analogue scale (VAS) to
record pain severity among patients.
All patients were assessed daily for efﬁcacy and safety
evaluations. Also, experienced nurses and geriatricians
provided proactive geriatric consultation to all patients.
The consultation was based on a structured multimodular
protocol (geriatric medical attention, enhancement of ori-
entation and cognition, sensory and mobility-improving
advice, attention to pain and sleeping problems, extra
attention to ﬂuid and food intake, and patient, family, and
nursing staff education) in order to minimized the chances
for delirium developing [24]. All patients were operated
under the same epidural anesthesia (15 ml 0.5% bupiva-
caine). Subcapital and trochanteric hip fractures were
treated with hemiarthroplasty and intramedullary nailing,
respectively.
If perioperative delirium occurred, patients were treated
according to standard procedures (haloperidol three times
per day, lorazepam three times per day, or both in
increasing doses, depending on symptoms of delirium) and
assessed for delirium severity and duration [4, 5]. Pain at
time of delirium occurrence was treated with pethidine
(50 mg intramuscularly).
Statistical calculations were performed using SPSS
version 11 (SPSS, Inc., Chicago, IL) for Windows.
For the primary analysis of the intervention, delirium
was considered a binary outcome (absent or present)
according to its earliest occurrence. The results are
expressed as relative risks with 95% conﬁdence intervals
(CIs) for the FICB group relative to the placebo group, with
a relative risk less than 1.0 indicating a beneﬁcial effect.
Statistical signiﬁcance was set at P\0.05.
Results
Of 324 patients initially admitted to our orthopaedic
department, 287 entered the baseline phase. Thirty-seven
patients were excluded; the reasons for not entering this
phase were: 13 refused to participate, 11 were taking
antipsychotic drugs, 4 were known to have Parkinsonism, 4
presented with pathologic hip fracture due to metastasis, 2
sustained acute myocardial infarction at admission, 2 were
delirious at admission, and 1 presented with an old hip
fracture. Of the 287 entering the baseline phase, 13 refused
treatment with the study drug and 2 patients died before
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123study treatment started. Fifty-three of 287 patients were not
randomized because all four risk factors were absent (low
risk). The remaining 219 eligible patients were random-
ized. Totally 12 patients were further excluded from both
groups for different reasons: six lost to follow-up, three
refused further participation, and three died (two pulmon-
ary embolism and one stroke) between second and fourth
day of admission. A ﬂow diagram of the study is presented
in Fig. 1.
Main features at the time of admission of the 102
patients randomized to FICB prophylaxis group and the
105 patients in the placebo group did not differ signiﬁ-
cantly (Table 1). The mean number of risk factors per
patient was similar in the two groups. Also the low
APACHE II scores and the high Barthel index scores
indicated good clinical condition for both groups.
Delirium occurred in 33 (15.94%) out of 207 patients
randomized to the FICB prophylaxis and placebo groups.
The incidence of delirium in the FICB prophylaxis group
was 10.78% (11/102), signiﬁcantly different from the
incidence (23.8%, 25/105) in the placebo group (relative
risk 0.45, 95% CI 0.23–0.87). The baseline features of
patients in the FICB prophylaxis and placebo groups who
developed delirium on follow-up did not differ signiﬁ-
cantly (Table 2).
Nine of 17 patients with high risk for delirium and
included in the FICB prophylaxis group developed delir-
ium, whereas 10 of 16 high-risk patients included in the
placebo group became delirious (relative risk 0.84, CI
0.47–1.52). Two of 85 patients with intermediate risk for
delirium and included in the FICB prophylaxis group
developed delirium, whereas 15 of 89 intermediate-risk
patients included in the placebo group became delirious
(relative risk 0.13, CI 0.03–0.53).
Although more ampules of paracetamol for intravenous
infusion and pethidine for intramuscular infusion were
 Patients  admitted 
(n=324) 
37 patients excluded 
Patients screened 
(n=287) 
13 denied participation                                                                   53 low risk patients   
2 died before study started 
  Randomized 
(n=219) 
FICB prophylaxis group (n=108)        Placebo group (n=111) 
      1 died                                2 died 
      3 denied to participate      4 lost at follow up         
      2 lost at follow up 
Completed trial (n=102)      Completed trial (n=105) 
-  Intermediate risk (n=85)  -  Intermediate risk (n=89)
-  High risk (n=17)                -  High risk (n=16) 
Fig. 1 Flow diagram of
patients enrolled in the study
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123administered in the placebo group for controlling pain (on
average 2.3 ampules of paracetamol/patient/day and 1.2
ampules of pethidine/patient/day and in the placebo group
versus 0.65 ampules of paracetamol/patient/day and 0.48
ampules of pethidine/patient/day in the FICB prophylaxis
group), no correlation between the number of ampules of
paracetamol or pethidine needed and delirium occurrence
was evidenced (r = 0.28, P = 0.62). According to the
VAS the pain scores in the two groups did not differ sig-
niﬁcantly (mean preoperative pain score of placebo group
versus FICB group were 68.2 and 61.4, respectively,
P = 0.59; mean postoperative pain score of placebo group
versus FICB group were 72.6 and 64.6, respectively,
P = 0.34).
Severity of delirium according to the highest value of
the DRSR-98 during an episode of delirium in patients
from the FICB prophylaxis group was on average
14.34 ± 3.6, versus 18.61 ± 3.4 in the placebo group
(mean difference 4.27, 95% CI 1.8–5.64, P\0.001).
Mean duration of delirium in the FICB prophylaxis
group was signiﬁcantly shorter than in the placebo group
(FICB 5.22 ± 4.28 days versus placebo 10.97 ± 7.16 days,
95% CI = 3.87–7.62, P\0.001).
There were no complications of FICB administration,
except three local hematomas developed at the injection
site which resolved spontaneously.
Discussion
Fascia iliaca compartment block is an anterior thigh
regional anesthetic block of lumbar plexus. As it is injected
into the fascia iliaca compartment, it spreads to nerves
innervating the hip and could reach the femoral and the
lateral cutaneous nerve of the thigh [15]. It then spreads
medially and proximally into a space between the psoas
and iliacus muscles, which act as a barrier to the substance,
reaching the obturator nerve in almost one-third of cases
[25].
Fascia iliaca compartment block technique is remark-
ably simple to learn and use. It is also considered to be
safe. The site of injection with the FICB is distant from any
nerves or blood vessels, which theoretically should elimi-
nate the possibility of intravascular or intraneural injection
[25]. However it is associated with rapid onset of pain
relief. Foss et al. [26] supported the use of FICB in acute
Table 1 Main features of 207
patients randomized to FICB






Age (years) 72.3 ± 4.1 73.1 ± 3.8 0.28
Female/male 78/24 76/29 0.54
Intertrochanteric/subcapital hip fracture 72/30 76/29 0.58
Barthel index 18.45 ± 1.32 18.52 ± 1.43 0.72
Geriatric Depression Scale 1.22 ± 1.04 1.18 ± 1.21 0.53
APACHE II score 12.89 ± 2.13 12.97 ± 1.82 0.56
MMSE score 24.1 ± 3.6 24.43 ± 3.2 0.83
Visual acuity 0.4 ± 0.12 0.42 ± 0.08 0.68
Dehydration index 20.15 ± 3.47 20.24 ± 3.15 0.49
Intermediate/high risk 85/17 89/16 0.62







Age (years) 81.4 ± 3.2 81.8 ± 2.9 0.72
Female/male 9/2 22/3 0.32
Intertrochanteric/subcapital hip fracture 7/4 18/7 0.48
Barthel index 18.87 ± 3.3 18.56 ± 4.2 0.73
Geriatric Depression Scale 1.2 ± 0.8 1.3 ± 0.62 0.52
APACHE II score 15 ± 2.8 15.4 ± 3.7 0.36
MMSE score 21.34 ± 3.2 21.12 ± 2.7 0.32
Visual acuity 0.30 ± 0.08 0.34 ± 0.01 0.06
Dehydration index 20.34 ± 5.1 20.96 ± 5.3 0.48
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123management of hip fracture pain because it is an effective
procedure. Forty-eight patients with hip fracture received
FICB injection in their study. They reported that FICB
provides excellent pain relief both at rest and on 15  leg lift
in hip fracture patients. Candal-Couto et al. [27] studied 30
patients with hip fracture who received FICB. They con-
cluded that this type of regional anesthesia can provide
signiﬁcant beneﬁt in the preoperative period and allow
patients to sit up more comfortably while they await sur-
gery. Monzo et al. [25] reported 63 patients who sustained
hip fracture and were administered a single dose of FICB.
They concluded that FICB injection produced signiﬁcant
beneﬁt by controlling pain, far better than standard par-
enteral medications, which lasted 8 h at least. Pain was
diminished dramatically in the ﬁrst 15 min after the
injection. Also they mentioned that analgesic requirements
after FICB injection were minimal. They also ﬁrst sug-
gested that FICB analgesic effect could be beneﬁcial for
preventing delirium after hip fracture.
In fact the relationship between pain and delirium has
been studied in patients recovering from hip fracture.
There is evidence from carefully controlled laboratory
studies that pain can impact on cognition and thus might
precipitate delirium, particularly in hip fracture patients.
Morrison et al. [28], in a large prospective study of 541
hip fractures, reported that 16% of patients became
delirious and that severe pain was associated with a
ninefold risk of developing delirium. Several studies
suggest that, when pain is managed in hip fracture
patients, delirium is reduced. Marcantonio et al. [11], in a
randomized study of hip fracture patients undergoing
surgery, reported that nine speciﬁc interventions, with pain
management also included, statistically reduced delirium
by one-third. Pain management in this study consisted of
round-the-clock acetaminophen (1 g, four times daily),
low-dose subcutaneous morphine early in the postopera-
tive period, and oxycodone later in the postoperative
period. In another study of hip fracture patients, a nurse-
led interdisciplinary intervention program for delirium was
implemented in the experimental group using a short-
acting weak opioid analgesic in combination with acet-
aminophen, while the control group received usual care.
Although the incidence of delirium occurrence was the
same in both groups, the patients in the experimental
group experienced much shorter duration of delirium, with
less severity [12].
Since Monzo et al. reported their belief that FICB pro-
phylaxis could prevent delirium occurrence, no trial has
studied the effect of FICB prophylaxis in preventing
delirium in hip fracture patients. Herein, this effect of FICB
prophylaxis is studied. According to our ﬁndings, there was
signiﬁcant difference in the incidence of delirium between
the FICB prophylaxis and placebo groups. However no
signiﬁcant difference was observed among high-risk
patients between the FICB prophylaxis and placebo groups
in terms of delirium incidence. On the other hand FICB
prophylaxis signiﬁcantly prevented delirium occurrence in
intermediate-risk patients. Thus FICB prophylaxis could be
beneﬁcial, particularly for intermediate-risk patients.
Additionally, severity and duration of delirium were sig-
niﬁcantly less in the intervention group. These ﬁndings
strongly suggest that FICB prophylaxis may lead to smaller
numbers of hip fracture patients developing delirium.
Moreover, FICB prophylaxis in our study was well
tolerated, and its low cost enhances the chances that this
intervention will be applied. Although patient controlled
analgesia (PCA) pumps and oral analgesics are alternative
treatments, they are associated with obvious disadvantages.
Crombez et al. [29] supported that, if a patient is in severe
pain, there will be cognitive interference and the patient
may not be able to complete the task of pushing the button
on the PCA pump. In these cases pain may get out of
control [30]. Also the beneﬁcial effect of FICB versus oral
analgesics has been evidenced [27].
This study has several limitations. Although we con-
trolled for perioperative risk factors for delirium, we did
not examine the impact of drugs other than paracetamol
and pethidine.
In conclusion, delirium incidence was reduced after
FICB injection in patients who had sustained hip fracture,
especially those who were at intermediate risk for this
complication. FICB, either in its own right or versus opioid
regimens, leads to better delirium outcomes.
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